Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PRIMAQUINE PHOSPHATE USP, with a corresponding US DMF Number 25258.
Remarkably, this DMF maintains an Active status since its submission on October 11, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 07, 2013, and payment made on July 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II